Journal
FRONTIERS IN MICROBIOLOGY
Volume 11, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fmicb.2020.01966
Keywords
Pseudomonas aeruginosa; Acinetobacter baumannii; carbapenem; colistin; RTI; IAI; UTI
Categories
Funding
- Merck & Co., Inc., Kenilworth, NJ, United States
- National Key Research and Development Program of China [2018YFC1200100, 2018YFC1200105]
- Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine [2016-I2M-3-014]
- Outstanding Talents Training Funding Project of Dongcheng District, Beijing
Ask authors/readers for more resources
Objective To investigate the incidence and susceptibilities of non-fermenting bacteria isolates from Chinese respiratory (RTI), intra-abdominal (IAI) and urinary tract (UTI) infections to antimicrobial agents between 2015 and 2017. Methods In total, 3,246 non-fermentative bacteria were collected from 21 hospitals and 9 hospital departments across 7 regions of China. A central testing laboratory was employed to determine antimicrobial susceptibilities using appropriate standards of interpretation. Results The majority of the isolates wereAcinetobacter baumannii(n= 1,360, 41.9%) andPseudomonas aeruginosa(n= 1,341, 41.3%). Overall multidrug resistance (MDR) and carbapenem resistance (CR) rates ofAcinetobacter baumanniiwere 80.1 and 78.7% with MDR and CR rates in RTIs, IAIs, and UTIs of 82.0 and 81.0%, 82.6 and 81.0% as well as 53.1 and 46.9%. Overall MDR and CR rates ofPseudomonas aeruginosaisolates were 36.2 and 38.9% with 41.8 and 44.3%, 29.3 and 36.1% as well as 24.2 and 20.2% MDR and CR rates in RTIs, IAIs, and UTIs. Overall susceptibility rates to imipenem, meropenem, amikacin, ciprofloxacin, cefepime and piperacillin-tazobactam were 21.1, 21.3, 33.0, 18.4, 19.2, and 19.6% forAcinetobacter baumanniiand 56.5, 58.5, 88.4, 63.1, 63.1, and 55.63% forPseudomonas aeruginosaisolates, whereas for colistin they were 95.7 and 94.6%, respectively. In all departments and regions of China, susceptibility rates ofPseudomonas aeruginosaandAcinetobacter baumanniiisolates to colistin were constantly above 80%. Conclusion Due to the high MDR and CR rates forPseudomonas aeruginosaandAcinetobacter baumannii, isolates obtained from RTIs, IAIs, and UTIs only maintained high susceptibility rates to colistin between 2015 and 2017.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available